Study programme 2020-2021 | Français | ||
Neurotoxicology & Safety Pharmacology | |||
Programme component of Master's in Biomedical Sciences à la Faculty of Medicine and Pharmacy |
Students are asked to consult the ECTS course descriptions for each learning activity (AA) to know what special Covid-19 assessment methods are possibly planned for the end of Q3 |
---|
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-M2-BIOMED-011-M | Optional UE | COLOMAR Aurore | M119 - Neurosciences |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Anglais | 30 | 0 | 0 | 0 | 0 | 4 | 4.00 | 1st term |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-DOYM-129 | Neurotoxicology and Safety Pharmacology | 30 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
Programme component | ||
---|---|---|
UM-M1-BIOMED-022-M Neuropharmacology |
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
cf AA description
Content of UE
The UE contains only one AA. Courses (30h) will be given in English during Q1 by Aurore Colomar (UMons). Topics will be approached theoretically by magistral courses and practically by presentation of scientific articles and case study in neurotoxicology and safety pharmacology. For the content description, please see the AA description.
Prior Experience
Not applicable
Type of Assessment for UE in Q1
Q1 UE Assessment Comments
oral presentation or participation during courses will be evaluated
written exam at the end of the session
Type of Assessment for UE in Q3
Q3 UE Assessment Comments
same as in Q1
Type of Resit Assessment for UE in Q1 (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
not applicable
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-DOYM-129 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-DOYM-129 |
|
Required Reading
AA | |
---|---|
M-DOYM-129 |
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-DOYM-129 | Not applicable |
Recommended Reading
AA | |
---|---|
M-DOYM-129 |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-DOYM-129 | Not applicable |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-DOYM-129 | Toxicologie clinique, de Baud & Garnier (2017) Lavoisier Médecine Ed. Handbook of developmental Neurotoxicology, Slikker et al. (2018) Academic Press Ed. |
Grade Deferrals of AAs from one year to the next
AA | Grade Deferrals of AAs from one year to the next |
---|---|
M-DOYM-129 | Authorized |